Drug profile · INN
paramethasone acetate
HALDRONE
paramethasone acetate (HALDRONE) is a glucocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — paramethasone acetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
paramethasone acetate (HALDRONE) is a glucocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is paramethasone acetate?
paramethasone acetate (HALDRONE) is a glucocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for paramethasone acetate?
HALDRONE is a marketed brand name for paramethasone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of paramethasone acetate?
paramethasone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.